BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 31 July 1997
No other water purification system can do this.
Pure H20 Bio-Technologies tested its water systems at a United States Food and Drug Administration-registered laboratory in New York. The results showed an unprecedented 100% "kill" against Cryptosporidium and other deadly bacterial pathogens, such as cholera and salmonella typhi.
"We're very excited about the results," said Joseph P. Doxey, president and CEO. "Our professional staff has worked hard to achieve this breakthrough. The response from around the world has been overwhelming -- we're ready to combat this disastrous situation."
H20 Bio-Technologies will be manufacturing residential and commercial water systems for retail sales and distribution. The company intends to sell its products through a national network of independent distributors. In line with its mission statement, its future objectives are to expand its Florida based network marketing system throughout the world with particular emphasis on Canada, North America and third world countries, where the market for the company's unique product range represents a fantastic opportunity for continued growth and increasing success.
--30--pp/mi*
CONTACT: International Buying Power Corp. 561/482-0004, (Fax) 561/488-2602
REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or 800-225-2030; SF 415-986-4422 or 800-227-0845; LA 310-820-9473 Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: http://www.businesswire.com
Copyright (c) 1997/BUSINESS WIRE. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854.
970731
BW970721
Copyright © 1997 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .